OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR‐200c suppresses TGF‐β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer
Wendong Bai, X. Ye, M. Zhang, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 6, pp. 1356-1368
Open Access | Times Cited: 162
Wendong Bai, X. Ye, M. Zhang, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 6, pp. 1356-1368
Open Access | Times Cited: 162
Showing 1-25 of 162 citing articles:
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si, Jiaying Shen, Huilin Zheng, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 595
Wengong Si, Jiaying Shen, Huilin Zheng, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 595
LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
Shengjia Shi, Lijuan Wang, Bo Yu, et al.
Oncotarget (2015) Vol. 6, Iss. 13, pp. 11652-11663
Open Access | Times Cited: 303
Shengjia Shi, Lijuan Wang, Bo Yu, et al.
Oncotarget (2015) Vol. 6, Iss. 13, pp. 11652-11663
Open Access | Times Cited: 303
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
Guangtao Pan, Yuhan Liu, Luorui Shang, et al.
Cancer Communications (2021) Vol. 41, Iss. 3, pp. 199-217
Open Access | Times Cited: 246
Guangtao Pan, Yuhan Liu, Luorui Shang, et al.
Cancer Communications (2021) Vol. 41, Iss. 3, pp. 199-217
Open Access | Times Cited: 246
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells
Richard Heery, Stephen P. Finn, Sinéad Cuffe, et al.
Cancers (2017) Vol. 9, Iss. 4, pp. 38-38
Open Access | Times Cited: 183
Richard Heery, Stephen P. Finn, Sinéad Cuffe, et al.
Cancers (2017) Vol. 9, Iss. 4, pp. 38-38
Open Access | Times Cited: 183
TGF-β Signaling and Resistance to Cancer Therapy
Maoduo Zhang, Ying Yi Zhang, Yongze Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125
Maoduo Zhang, Ying Yi Zhang, Yongze Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125
Breast cancer stem cells, EMT and therapeutic targets
Srishti Kotiyal, Susinjan Bhattacharya
Biochemical and Biophysical Research Communications (2014) Vol. 453, Iss. 1, pp. 112-116
Closed Access | Times Cited: 168
Srishti Kotiyal, Susinjan Bhattacharya
Biochemical and Biophysical Research Communications (2014) Vol. 453, Iss. 1, pp. 112-116
Closed Access | Times Cited: 168
The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity
Ming‐xin Cao, Yaping Jiang, Ya‐ling Tang, et al.
Oncotarget (2016) Vol. 8, Iss. 7, pp. 12472-12483
Open Access | Times Cited: 158
Ming‐xin Cao, Yaping Jiang, Ya‐ling Tang, et al.
Oncotarget (2016) Vol. 8, Iss. 7, pp. 12472-12483
Open Access | Times Cited: 158
Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
Jente van Staalduinen, D.A. Baker, Peter ten Dijke, et al.
Oncogene (2018) Vol. 37, Iss. 48, pp. 6195-6211
Closed Access | Times Cited: 154
Jente van Staalduinen, D.A. Baker, Peter ten Dijke, et al.
Oncogene (2018) Vol. 37, Iss. 48, pp. 6195-6211
Closed Access | Times Cited: 154
New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
Isabel Fabregat, Andrea Malfettone, Jitka Soukupová
Journal of Clinical Medicine (2016) Vol. 5, Iss. 3, pp. 37-37
Open Access | Times Cited: 136
Isabel Fabregat, Andrea Malfettone, Jitka Soukupová
Journal of Clinical Medicine (2016) Vol. 5, Iss. 3, pp. 37-37
Open Access | Times Cited: 136
RETRACTED ARTICLE: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
Huaying Dong, Wei Wang, Shaowei Mo, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 134
Huaying Dong, Wei Wang, Shaowei Mo, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 134
Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
Hua-Tao Wu, Huiting Zhong, Guanwu Li, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 134
Hua-Tao Wu, Huiting Zhong, Guanwu Li, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 134
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment
Parham Jabbarzadeh Kaboli, Asmah Rahmat, Patimah Ismail, et al.
Pharmacological Research (2015) Vol. 97, pp. 104-121
Open Access | Times Cited: 132
Parham Jabbarzadeh Kaboli, Asmah Rahmat, Patimah Ismail, et al.
Pharmacological Research (2015) Vol. 97, pp. 104-121
Open Access | Times Cited: 132
Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma
Qiulian Li, Chao Zhang, Ruichao Chen, et al.
Cancer Letters (2016) Vol. 383, Iss. 1, pp. 28-40
Closed Access | Times Cited: 130
Qiulian Li, Chao Zhang, Ruichao Chen, et al.
Cancer Letters (2016) Vol. 383, Iss. 1, pp. 28-40
Closed Access | Times Cited: 130
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
Monica Fedele, Laura Cerchia, Gennaro Chiappetta
Cancers (2017) Vol. 9, Iss. 10, pp. 134-134
Open Access | Times Cited: 130
Monica Fedele, Laura Cerchia, Gennaro Chiappetta
Cancers (2017) Vol. 9, Iss. 10, pp. 134-134
Open Access | Times Cited: 130
The roles of ZEB1 in tumorigenic progression and epigenetic modifications
Yu Zhang, Lei Xu, Anqi Li, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 400-408
Open Access | Times Cited: 128
Yu Zhang, Lei Xu, Anqi Li, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 400-408
Open Access | Times Cited: 128
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
Merve Mutlu, Umar Raza, Özge Saatci, et al.
Journal of Molecular Medicine (2016) Vol. 94, Iss. 6, pp. 629-644
Closed Access | Times Cited: 127
Merve Mutlu, Umar Raza, Özge Saatci, et al.
Journal of Molecular Medicine (2016) Vol. 94, Iss. 6, pp. 629-644
Closed Access | Times Cited: 127
Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance
Alex J. Gooding, William P. Schiemann
Molecular Cancer Research (2020) Vol. 18, Iss. 9, pp. 1257-1270
Open Access | Times Cited: 115
Alex J. Gooding, William P. Schiemann
Molecular Cancer Research (2020) Vol. 18, Iss. 9, pp. 1257-1270
Open Access | Times Cited: 115
Functional miRNAs in breast cancer drug resistance
Weizi Hu, Chunli Tan, Yunjie He, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 1529-1541
Open Access | Times Cited: 113
Weizi Hu, Chunli Tan, Yunjie He, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 1529-1541
Open Access | Times Cited: 113
MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
Qingling Yang, Yangyang Wang, Xiaohui Lü, et al.
Oncotarget (2014) Vol. 6, Iss. 5, pp. 3268-3279
Open Access | Times Cited: 105
Qingling Yang, Yangyang Wang, Xiaohui Lü, et al.
Oncotarget (2014) Vol. 6, Iss. 5, pp. 3268-3279
Open Access | Times Cited: 105
Jen Nee Goh, Ser Yue Loo, Arpita Datta, et al.
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2015) Vol. 91, Iss. 2, pp. 409-428
Closed Access | Times Cited: 102
Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217
Jason J. Northey, Alexander Barrett, Irene Acerbi, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 5721-5737
Open Access | Times Cited: 98
Jason J. Northey, Alexander Barrett, Irene Acerbi, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 5721-5737
Open Access | Times Cited: 98
Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
Jia Ma, Binbin Fang, Fanpeng Zeng, et al.
Oncotarget (2015) Vol. 6, Iss. 3, pp. 1740-1749
Open Access | Times Cited: 93
Jia Ma, Binbin Fang, Fanpeng Zeng, et al.
Oncotarget (2015) Vol. 6, Iss. 3, pp. 1740-1749
Open Access | Times Cited: 93
Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma
Song Xu, Xiaoming Yi, Chaopeng Tang, et al.
Oncology Reports (2016) Vol. 36, Iss. 1, pp. 10-22
Open Access | Times Cited: 87
Song Xu, Xiaoming Yi, Chaopeng Tang, et al.
Oncology Reports (2016) Vol. 36, Iss. 1, pp. 10-22
Open Access | Times Cited: 87
Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis
Artur Nieszporek, Klaudia Skrzypek, Grażyna Adamek, et al.
Acta Biochimica Polonica (2019)
Open Access | Times Cited: 85
Artur Nieszporek, Klaudia Skrzypek, Grażyna Adamek, et al.
Acta Biochimica Polonica (2019)
Open Access | Times Cited: 85
Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-β signaling pathway
Dai-Yu Sun, Jiaqi Wu, Zhiheng He, et al.
Life Sciences (2019) Vol. 235, pp. 116791-116791
Closed Access | Times Cited: 79
Dai-Yu Sun, Jiaqi Wu, Zhiheng He, et al.
Life Sciences (2019) Vol. 235, pp. 116791-116791
Closed Access | Times Cited: 79
